2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Published: October 30, 2017
- Ventricular Arrhythmia (VA) includes a spectrum of conditions with clinical presentation that ranges from no symptoms to cardiac arrest. Sudden cardiac arrest (SCA), the “sudden cessation of cardiac activity,” progresses to Sudden Cardiac Death (SCD) if not treated quickly. SCA and SCD account for almost half of all cardiovascular deaths.
- Risks of VA and SCD vary in specific populations with different underlying cardiac conditions and with specific family history and genetic variants.
- This guideline provides instruction for the management of adults who have VA or are at a risk of SCD and covers diseases and syndromes associated with a risk of SCD from VA.
Supporting Materials
- Top Things to Know: 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
- Executive Summary
- Systematic Review
- Slide Set: Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (PDF)
- AHA News: New guidelines aim to prevent sudden cardiac death
- News Release: Societies Detail Treatment for Patients With Ventricular Arrhythmias
Recommended Reading
- 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
- 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
- 2011 Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
- 2012 Focused Update Incorporated Into the2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
- Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death